773063-99-3 Usage
Uses
Used in Pharmaceutical Industry:
(E)-3-([1,4'-Bipiperidin]-1'-ylmethyl)-N-(4-chloro-2-(2-(3,4-dimethylbenzylidene)hydrazinecarbonyl)phenyl)benzamide is used as a therapeutic agent for addressing medical conditions such as pain, inflammation, and anxiety. Its ability to inhibit the FAAH enzyme suggests potential benefits in modulating the endocannabinoid system, which plays a crucial role in these conditions.
Used in Medicinal Chemistry Research:
(E)-3-([1,4'-Bipiperidin]-1'-ylmethyl)-N-(4-chloro-2-(2-(3,4-dimethylbenzylidene)hydrazinecarbonyl)phenyl)benzamide serves as a subject of interest for further research and development within the field of medicinal chemistry. Its unique structure and activity provide opportunities for exploring new approaches to drug discovery and the optimization of pharmaceutical agents targeting the endocannabinoid system.
Used in Drug Development:
(E)-3-([1,4'-Bipiperidin]-1'-ylmethyl)-N-(4-chloro-2-(2-(3,4-dimethylbenzylidene)hydrazinecarbonyl)phenyl)benzamide is utilized in the development of new drugs that can potentially offer more effective treatments for a range of disorders. Its role as a FAAH inhibitor highlights its potential in creating medications that can alleviate symptoms and improve the quality of life for patients suffering from pain, inflammation, and anxiety-related conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 773063-99-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,3,0,6 and 3 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 773063-99:
(8*7)+(7*7)+(6*3)+(5*0)+(4*6)+(3*3)+(2*9)+(1*9)=183
183 % 10 = 3
So 773063-99-3 is a valid CAS Registry Number.
773063-99-3Relevant academic research and scientific papers
COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME
-
Page/Page column 84, (2010/11/08)
An objective of the present invention is to provide compounds that can effectively suppress the concentration of phosphorus in serum to effectively prevent or treat diseases induced by an increase in concentration of phosphate in serum. The compounds according to the present invention are compounds represented by formula (I) and pharmaceutically acceptable salts and solvates thereof: wherein A represents an optionally substituted five- to nine-membered unsaturated carbocyclic moiety or a five- to nine-membered unsaturated heterocyclic moiety, and ---- represents a single bond or a double bond, R5 represents optionally substituted aryl or the like, Z represents - N=CHR6R7 or the like, R6 and R7 represent H, optionally substituted alkyl, optionally substituted aryl or the like, R101 and R102 together form =O, and R103 and R104 represent H, or R101 and R104 together from a bond, and R102 and R103 together form a bond.
